ARCHIVES

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

This article is from The Cancer Letter archive.

Vol. 20 No. 02 | January 14, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Cancer Panel Report Urges Removal Of Barriers To Care.

December 7, 2001

AACR Statement on Precancers Plays Key Role in NCI Agenda

May 30, 2003

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

Research Needed To Improve Survival In Adolescents, Young Adults With Cancer

January 26, 2007

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989